| scholarly article | Q13442814 |
| P2093 | author name string | Robert A Bonomo | |
| Jonathan Ho | |||
| John P Dekker | |||
| Jung-Ho Youn | |||
| Juan Gea-Banacloche | |||
| Mark Parta | |||
| Pavel P Khil | |||
| Karen M Frank | |||
| Augusto Dulanto Chiang | |||
| Jamie K Lemon | |||
| P2860 | cites work | Rates of spontaneous mutation | Q24548000 |
| Evolution of the mutation rate | Q24602069 | ||
| Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations | Q27005741 | ||
| Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa | Q27654653 | ||
| A constant rate of spontaneous mutation in DNA-based microbes | Q28271032 | ||
| Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa | Q28492484 | ||
| Role of intracellular proteases in the antibiotic resistance, motility, and biofilm formation of Pseudomonas aeruginosa | Q28492978 | ||
| Comprehensive transposon mutant library of Pseudomonas aeruginosa | Q29614861 | ||
| Escherichia coli mutator genes | Q33539352 | ||
| Hypermutation in bacteria and other cellular systems | Q33770256 | ||
| Evolution-driving genes | Q33949870 | ||
| Direct selection for mutators in Escherichia coli. | Q33991388 | ||
| Mutator bacteria as a risk factor in treatment of infectious diseases | Q34113782 | ||
| Error catastrophe and antiviral strategy | Q34153584 | ||
| DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis | Q34191816 | ||
| The rise and fall of mutator bacteria. | Q34392588 | ||
| Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. | Q34412265 | ||
| Sequence-verified two-allele transposon mutant library for Pseudomonas aeruginosa PAO1. | Q34415790 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome | Q34533276 | ||
| The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness | Q34609052 | ||
| The fate of microbial mutators | Q34623647 | ||
| Specialized DNA polymerases, cellular survival, and the genesis of mutations | Q34662609 | ||
| DNA repair systems and bacterial evolution | Q35132444 | ||
| The role of mutators in the emergence of antibiotic-resistant bacteria | Q35177659 | ||
| Proliferation of mutators in A cell population | Q35618973 | ||
| Survival versus maintenance of genetic stability: a conflict of priorities during stress | Q35811210 | ||
| The properties of spontaneous mutations in the opportunistic pathogen Pseudomonas aeruginosa | Q35885995 | ||
| In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase | Q35960745 | ||
| General and inducible hypermutation facilitate parallel adaptation in Pseudomonas aeruginosa despite divergent mutation spectra. | Q36187249 | ||
| Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing. | Q36339832 | ||
| Predicting the impact of Lynch syndrome-causing missense mutations from structural calculations | Q36350781 | ||
| β-Lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity | Q36737307 | ||
| Structure and mechanism for DNA lesion recognition | Q37044560 | ||
| Environmentally Endemic Pseudomonas aeruginosa Strains with Mutations in lasR Are Associated with Increased Disease Severity in Corneal Ulcers | Q37239538 | ||
| Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance | Q37794342 | ||
| Microbiological effects of sublethal levels of antibiotics. | Q38214805 | ||
| The frequency of mutators in populations of Escherichia coli | Q38304923 | ||
| Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome | Q38355288 | ||
| Evolutionary Trajectories to Antibiotic Resistance | Q38683839 | ||
| Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates. | Q38741337 | ||
| Genetic drift, selection and the evolution of the mutation rate | Q38980350 | ||
| Bacterial proteases, untapped antimicrobial drug targets | Q39023951 | ||
| High frequency of mutator strains among human uropathogenic Escherichia coli isolates. | Q39694657 | ||
| The rapid in vivo evolution of Pseudomonas aeruginosa in ventilator-associated pneumonia patients leads to attenuated virulence. | Q40063913 | ||
| In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases | Q40315371 | ||
| Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC | Q41075944 | ||
| First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate. | Q41098656 | ||
| Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC. | Q41508049 | ||
| Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years | Q41560657 | ||
| Emergence of Ceftolozane-Tazobactam Resistant Pseudomonas aeruginosa During Treatment is Mediated by a Single AmpC Structural Mutation. | Q41994337 | ||
| Genome sequencing and characterization of an extensively drug-resistant sequence type 111 serotype O12 hospital outbreak strain of Pseudomonas aeruginosa | Q42232987 | ||
| Competition between high- and higher-mutating strains of Escherichia coli | Q42736352 | ||
| Extended-spectrum cephalosporinases in Pseudomonas aeruginosa | Q43128351 | ||
| Mutations in the conserved glycine and serine of the MutS ABC signature motif affect nucleotide exchange, kinetics of sliding clamp release of mismatch and mismatch repair | Q43231958 | ||
| Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. | Q44012036 | ||
| Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance | Q44144059 | ||
| Stress-induced mutagenesis in bacteria | Q44459277 | ||
| Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa | Q45897898 | ||
| Successive emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in blaKPC-2-harboring Klebsiella pneumoniae ST307. | Q47269615 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment. | Q51736590 | ||
| Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. | Q54073909 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| High mutation rates limit evolutionary adaptation in Escherichia coli. | Q55285004 | ||
| Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut | Q56944626 | ||
| Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli | Q56944671 | ||
| Multidrug efflux pumps: structure, function and regulation | Q57722260 | ||
| Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis | Q61589152 | ||
| Identifying and exploiting genes that potentiate the evolution of antibiotic resistance | Q63438192 | ||
| Rapid genetic and phenotypic changes in Pseudomonas aeruginosa clinical strains during ventilator-associated pneumonia | Q64083071 | ||
| Molecular self-organization and the early stages of evolution | Q70639134 | ||
| Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance | Q79162727 | ||
| The error threshold | Q81268912 | ||
| COMPETITION BETWEEN HIGH AND LOW MUTATING STRAINS OF ESCHERICHIA COLI | Q88206326 | ||
| Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either Ceftazidime or Ceftazidime-Avibactam | Q90784484 | ||
| Antibiotic-Induced Genetic Variation: How It Arises and How It Can Be Prevented | Q91364606 | ||
| P433 | issue | 5 | |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| DNA mismatch repair | Q2984243 | ||
| rapid evolution | Q118582888 | ||
| P577 | publication date | 2019-09-17 | |
| P1433 | published in | mBio | Q15817061 |
| P1476 | title | Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in Pseudomonas aeruginosa Acute Infection | |
| P478 | volume | 10 |
Search more.